I agree that this site is using cookies. You can find further informations here.
X
Herbst, Roy
468  results:
Search for persons X
?
1

A process to reanalyze clinical DNA sequencing data for bio..:

Neal, Joel W ; Minichiello, Katherine ; Brennick, Ryan...
The Oncologist.  29 (2024)  6 - p. e843-e847 , 2024
Link: https://doi.org/10.1093/..
 
?
2

Disparities in COVID-19 vaccine hesitancy among a diverse c..:

Eger, William H. ; Suttiratana, Sakinah C. ; Herbst, Roy L....
Preventive Medicine Reports.  34 (2023)  - p. 102263 , 2023
Link: https://doi.org/10.1016/..
 
?
3

ANtiangiogenic Second-line Lung cancer Meta-Analysis on ind..:

Remon, Jordi ; Lacas, Benjamin ; Herbst, Roy...
European Journal of Cancer.  166 (2022)  - p. 112-125 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Programmed Death-Ligand 1 and Programmed Death-Ligand 2 mRN..:

Fernandez, Aileen I. ; Gavrielatou, Niki ; McCann, Leena...
Journal of Thoracic Oncology.  17 (2022)  9 - p. 1078-1085 , 2022
Link: https://doi.org/10.1016/..
 
?
5

A Network Meta-Analysis of Cancer Immunotherapies Versus Ch..:

Herbst, Roy ; Jassem, Jacek ; Abogunrin, Seye...
Frontiers in Oncology.  11 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
6

SC14.01 Immunotherapy in the First-Line Setting of Advanced..:

Herbst, Roy
Journal of Thoracic Oncology.  12 (2017)  1 - p. S107-S108 , 2017
Link: https://doi.org/10.1016/..
 
?
7

MA16.02 Mutational Landscape of TKI Naïve and Resistant EGF..:

Hastings, Katherine ; Choi, Jungmin ; Wurtz, Anna...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S435 , 2017
Link: https://doi.org/10.1016/..
 
?
8

MA15.06 Predictive Value of Measuring Somatic Mutations and..:

Gettinger, Scott ; Choi, Jungmin ; Mani, Nikita...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S430-S431 , 2017
Link: https://doi.org/10.1016/..
 
?
9

MA16.10 Lung-MAP (S1400) Lung Master Protocol: Accrual and ..:

Papadimitrakopoulou, Vassiliki ; Redman, Mary ; Gandara, David R....
Journal of Thoracic Oncology.  12 (2017)  1 - p. S439-S440 , 2017
Link: https://doi.org/10.1016/..
 
?
10

P3.02c-042 IMpower110: Phase III Trial Comparing 1L Atezoli..:

De Marinis, Filippo ; Jassem, Jacek ; Spigel, David...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S1299-S1300 , 2017
Link: https://doi.org/10.1016/..
 
?
11

P1.05-017 The Prognostic Impact of EGFR, KRAS and TP53 Soma..:

Rothberg, Bonnie Gould ; Das, Rahul ; Jackson, Laura...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S623-S624 , 2017
Link: https://doi.org/10.1016/..
 
?
12

P3.02c-088 Acquired Resistance to Programmed Death-1 Axis I..:

Choi, Jungmin ; Sowell, Ryan ; Truini, Anna...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S1331-S1332 , 2017
Link: https://doi.org/10.1016/..
 
?
13

OA03.07 KEYNOTE-010: Durable Clinical Benefit in Patients w..:

Herbst, Roy ; Garon, Edward ; Kim, Dong-Wan...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S254-S255 , 2017
Link: https://doi.org/10.1016/..
 
?
14

P2.01-046 Quantitative Measurement of B7-H3 Protein Express..:

Altan, Mehmet ; Pelekanou, Vasiliki ; Schalper, Kurt...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S813-S814 , 2017
Link: https://doi.org/10.1016/..
 
?
15

P3.02c-048 A Phase I/II Trial Evaluating the Combination of..:

Decker, Roy ; Goldberg, Sarah ; Nath, Sameer...
Journal of Thoracic Oncology.  12 (2017)  1 - p. S1303-S1304 , 2017
Link: https://doi.org/10.1016/..
 
1-15